Novartis in trouble in India
Talk about being stuck between a rock and a hard place; but what is Novartis supposed to do about its current problems over patents relating to its cancer treatment Glivec (Gleevec) in India? As the company must have expected, it is now facing a…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.